Hartline Investment Corp’s Johnson & Johnson JNJ Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2024
Q2
Sell
-22,741
Closed -$3.6M 287
2024
Q1
$3.6M Buy
+22,741
New +$3.62M 0.63% 35
2022
Q4
Sell
-2,132
Closed -$348K 153
2022
Q3
$348K Buy
+2,132
New +$361K 0.29% 87
2019
Q2
Sell
-1,682
Closed -$235K 113
2019
Q1
$235K Hold
1,682
0.06% 104
2018
Q4
$217K Sell
1,682
-15
-0.9% -$2.09K 0.07% 107
2018
Q3
$234K Hold
1,697
0.05% 103
2018
Q2
$206K Hold
1,697
0.06% 98
2018
Q1
$217K Buy
1,697
+125
+8% +$16.9K 0.06% 101
2017
Q4
$220K Buy
1,572
+6
+0.4% +$836 0.06% 106
2017
Q3
$204K Hold
1,566
0.06% 105
2017
Q2
$207K Buy
+1,566
New +$200K 0.07% 104
2015
Q2
Sell
-2,073
Closed -$209K 108
2015
Q1
$209K Buy
2,073
+30
+1% +$3.05K 0.07% 105
2014
Q4
$214K Hold
2,043
0.07% 106
2014
Q3
$218K Buy
+2,043
New +$212K 0.08% 106

Other funds holding JNJ

Hartline Investment Corp's JNJ Position: Q2 2024 in Review

Hartline Investment Corp sold out of Johnson & Johnson (JNJ) in Q2 2024, closing a stake of 22,741 shares — an estimated $3.6M sold.

Hartline Investment Corp first reported a position in JNJ in Q3 2014 and held it in 13 quarters. The position peaked at $3.6M in Q1 2024. 3,801 funds tracked by Wall St. Rank hold JNJ as of Q2 2024.

  • Hartline Investment Corp reported no remaining Johnson & Johnson position as of Q2 2024 after selling out during the quarter.
  • Hartline Investment Corp sold 22,741 Johnson & Johnson shares in Q2 2024, an estimated $3.6M.
  • Hartline Investment Corp first reported a position in Johnson & Johnson in Q3 2014 and held it in 13 quarters.
  • Hartline Investment Corp's Johnson & Johnson position peaked at $3.6M in Q1 2024.
  • 3,801 funds tracked by Wall St. Rank held Johnson & Johnson as of Q2 2024.

Based on Hartline Investment Corp's 13F filing for Q2 2024, filed 9 Aug 2024.